Syros Pharmaceuticals (SYRS) IPO Opens Up 20%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- HSBC Downgrades IBM (IBM) to Reduce, 'Stretched Valuation'
Syros Pharmaceuticals (SYRS) IPO Pushes Higher Into the Close
June 30, 2016 3:10 PM EDTToday's IPO for Syros Pharmaceuticals (NASDAQ: SYRS) is pressing higher into the close. Shares last traded up 46.8% to $18.35 after pricing at $12.50 and opening at $15 earlier today.
... MoreSyros Pharmaceuticals (SYRS) Prices 4M Common Stock IPO at $12.50/Share, Under Expected Range
June 30, 2016 6:26 AM EDTSyros Pharmaceuticals (Nasdaq: SYRS) announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share, before underwriting discounts and commissions. In addition, Syros has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock from Syros at the public offering price, less the underwriting discount and commissions, to cover over-allotments, if any. All of the shares are being offered by Syros Pharmaceuticals. The Companys shares are scheduled to begin trading on The NASDAQ Global Select Market on June 30,... More
